Patents-Review.com
ClassID:

21060 ⎘

A61K39/0005 - CPC Classification

Classification description:

Medicinal preparations containing antigens or antibodies Vertebrate antigens

Sub-classes:
Recent Application in this class:
#1
20260115300
2026-04-30

GLYCOTARGETING THERAPEUTICS

 #2
20260108600
2026-04-23

METHODS AND COMPOSITIONS RELATING TO IMPROVED IONIC LIQUID ADJUVANTS

 #3
20260102489
2026-04-16

COMBINATION OF VACCINATION AND INHIBITION OF THE PD-1 PATHWAY

 #4
20260097094
2026-04-09

METHODS FOR INHIBITING DIAZEPAM BINDING PROTEIN

 #5
20260053901
2026-02-26

ANTIGEN COMPOSITION, COMPOSITION FOR ANTIGEN EXPRESSION, AND ANTIBODY COMPOSITION

 #6
20260041746
2026-02-12

TRANSIENT EXPRESSION SYSTEM FOR RNA, FOR VACCINATION

 #7
20260041745
2026-02-12

NOVEL CRS FRAGMENT PEPTIDE WITH IMMUNOPOTENTIATING ACTIVITY, AND USE THEREOF

 #8
20260027201
2026-01-29

Methods of Treating Glioblastoma

 #9
20260022194
2026-01-22

METHOD FOR PREPARING ANTIBODY-CONTAINING FORMULATION

 #10
20260007729
2026-01-08

IMMUNIZATION AGAINST VIRAL INFECTIONS DISEASE(S)

 #11
20260000743
2026-01-01

IMMUNOGENIC COMPOSITIONS COMPRISING NUCLEIC ACIDS FOR RAS PEPTIDES

 #12
20260000742
2026-01-01

THERAPEUTIC OR PREVENTIVE AGENT FOR MYOCARDIAL INFARCTION, CARDIAC FIBROSIS, OR HEART FAILURE USING Htra3 AS THERAPEUTIC TARGET

 #13
20250346684
2025-11-13

BINDING MOLECULES FOR BCMA AND CD3

 #14
20250332233
2025-10-30

REPLICANT / STAV FOR DISEASE TREATMENT AND METHODS OF USE

 #15
20250319171
2025-10-16

COMPOSITIONS AND METHODS FOR PREVENTING TUMORS AND CANCER

 #16
20250304667
2025-10-02

COMPLEMENT COMPONENT C5 ANTIBODIES

 #17
20250295743
2025-09-25

GLYCOTARGETING THERAPEUTICS

 #18
20250281582
2025-09-11

TREATMENT OF PRURITUS IN HORSES

 #19
20250281405
2025-09-11

POLYMERSOMES COMPRISING A SOLUBLE ENCAPSULATED POLYNUCLEOTIDE AND AN IONIZABLE LIPID AS WELL AS METHODS OF MAKING AND USES THEREOF

 #20
20250268836
2025-08-28

MICROSPHERE FORMULATIONS COMPRISING MULTIPLE NON-IDENTICAL PEPTIDES AND METHODS FOR MAKING THE SAME

 #21
20250205320
2025-06-26

METHODS OF TREATING POLYCYSTIC KIDNEY DISEASE

 #22
20250195674
2025-06-19

IMMUNOSTIMULATORY COMPOSITIONS AND METHODS OF USE THEREOF

 #23
20250195631
2025-06-19

ANTIGEN DELIVERING SALMONELLA FOR USE AS A TUMOR HOMING BEACON TO REFOCUS PREEXISTING, VACCINE GENERATED T CELLS TO COMBAT CANCER

 #24
20250136716
2025-05-01

METHOD FOR PREPARING ANTIBODY-CONTAINING FORMULATION

 #25
20250127879
2025-04-24

NEWCASTLE DISEASE VIRUSES AND USES THEREOF

 #26
20250114429
2025-04-10

VISTA ANTAGONIST AND METHODS OF USE

 #27
20250108103
2025-04-03

OIL-BASED ADJUVANTS

 #28
20250082753
2025-03-13

CHIMERIC RECEPTORS

 #29
20250066439
2025-02-27

RECOMBINANT PROTEINS AND THEIR THERAPEUTIC USES

 #30
20250059256
2025-02-20

HER-1, HER-3 AND IGF-1R COMPOSITIONS AND USES THEREOF

 #31
20250057928
2025-02-20

VACCINE COMPOSITION FOR INDUCING ANTI-IL-23 ANTIBODY

 #32
20250009858
2025-01-09

Peptide Conjugated Particles

 #33
20240425557
2024-12-26

Albumin Bound Macromolecule Tri-Agonist Activating GLP-1/GIP/Glucagon Receptors

 #34
20240424072
2024-12-26

Albumin Bound Macromolecule Tri-Agonist Activating GLP 1/GIP/Glucagon Receptors And Methods Therefor

 #35
20240400634
2024-12-05

PEPTIDE IMMUNOGENS TARGETING ISLET AMYLOID POLYPEPTIDE (IAPP) AND FORMULATIONS THEREOF FOR PREVENTION AND TREATMENT OF DISORDERS RELATED TO AGGREGATED IAPP

 #36
20240368574
2024-11-07

DUAL CONTROLS FOR THERAPEUTIC CELL ACTIVATION OR ELIMINATION

 #37
20240358652
2024-10-31

LIPID NANOPARTICLE FORMULATIONS

 #38
20240350598
2024-10-24

Anti-Abeta Therapeutic Vaccines

 #39
20240316192
2024-09-26

Engineered immune effector cells for cancer immunotherapy that are resistant to fratricide by virtue of having genetically modified surface antigens

 #40
20240316168
2024-09-26

Immunomodulatory Therapy For Type 1 Diabetes Mellitus Autoimmunity

 #41
20240316167
2024-09-26

TREATMENT OF URTICARIA

 #42
20240307533
2024-09-19

Reducing side effects of immunotherapy using genetically modified hematopoietic cells

 #43
20240299510
2024-09-12

ANTIBODY-GUIDED PCSK9-MIMICKING IMMUNOGENS LACKING 9-RESIDUE SEQUENCE OVERLAP WITH HUMAN PROTEINS

 #44
20240294602
2024-09-05

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #45
20240279317
2024-08-22

COMPLEMENT COMPONENT C5 ANTIBODIES

 #46
20240269275
2024-08-15

Immunotherapy of cancer patients using CAR T or CAR NK cells combined with hematopoietic cells that have a modified or deleted target antigen

 #47
20240254256
2024-08-01

Human Anti-SOD1 Antibodies

 #48
20240245750
2024-07-25

METHODS FOR INHIBITING DIAZEPAM BINDING PROTEIN

 #49
20240207379
2024-06-27

STRATEGIES TO PREVENT AND/OR TREAT IMMUNE RESPONSES TO SOLUBLE ALLOFACTORS

 #50
20240207378
2024-06-27

BETA-2 MICROGLOBULIN-DEFICIENT CELLS

 #51
20240197844
2024-06-20

PEPTIDE VACCINES USABLE FOR HYPERCHOLESTEROLEMIA RELATED DISEASES

 #52
20240158507
2024-05-16

VISTA Antagonist and Methods of Use

 #53
20240158464
2024-05-16

IMMUNOGENIC PEPTIDES AND THEIR USE IN TRANSPLANTATION

 #54
20240156721
2024-05-16

Method for preparing self-assembled nanoparticle releasing soluble microneedle structure

 #55
20240141068
2024-05-02

ACTIVATION OF (NA++K+)-ATPASE INHIBITS PLATELET AGGREGATION AND PREVENTS THROMBOSIS

 #56
20240108869
2024-04-04

Active Agent Delivery Devices and Methods of Using the same

 #57
20240108716
2024-04-04

MONOVALENT AND MULTIVALENT VACCINES FOR PREVENTION AND TREATMENT OF DISEASE

 #58
20240082371
2024-03-14

PEPTIDE CONJUGATED PARTICLES

 #59
20240058430
2024-02-22

TRANSIENT EXPRESSION SYSTEM FOR RNA, FOR VACCINATION

 #60
20240050437
2024-02-15

HETEROCYCLIC COMPOUNDS AND USES THEREOF

 #61
20240041994
2024-02-08

CMV VACCINE AND METHOD OF MAKING AND USING THE SAME

 #62
20240000930
2024-01-04

METHODS AND COMPOSITIONS FOR TREATING KIDNEY DISEASES

 #63
20240000913
2024-01-04

Oil-based adjuvants

 #64
20240000830
2024-01-04

IMMUNE-MODIFYING NANOPARTICLES FOR THE TREATMENT OF INFLAMMATORY DISEASES

 #65
20230414550
2023-12-28

COMBINATION OF KYNURENINE AND ANTIGEN PRESENTING CELLS (APC) AS THERAPEUTICS AND METHODS FOR THEIR USE IN IMMUNE MODULATION

 #66
20230406902
2023-12-21

PEPTIDE MIMOTOPES OF CLAUDIN 18.2 AND USES THEREOF

 #67
20230348563
2023-11-02

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #68
20230346924
2023-11-02

MRNA VACCINE COMPRISING ADJUVANT CAPABLE OF KINETIC CONTROL

 #69
20230310561
2023-10-05

IMMUNOGENIC COMPOSITION TARGETING PHOSPHORYLATED TAU PROTEIN

 #70
20230287111
2023-09-14

MULTIPARTITE SIGNALING PROTEINS AND USES THEREOF

 #71
20230285553
2023-09-14

MATERIALS AND METHODS FOR MITIGATING IMMUNE-SENSITIZATION

 #72
20230265158
2023-08-24

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #73
20230248823
2023-08-10

Combination of immune effector cells specific for a target antigen and hematopoietic calls that express the target antigen in an altered form

 #74
20230235016
2023-07-27

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #75
20230235015
2023-07-27

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #76
20230235014
2023-07-27

PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #77
20230203127
2023-06-29

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #78
20230158131
2023-05-25

COMBINATION OF VACCINATION AND INHIBITION OF THE PD-1 PATHWAY

 #79
20230151076
2023-05-18

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #80
20230142694
2023-05-11

METHODS FOR TREATING LIVER DISEASE

 #81
20230115331
2023-04-13

GLYCOTARGETING THERAPEUTICS

 #82
20230113246
2023-04-13

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #83
20230101046
2023-03-30

ANAPLASTIC LYMPHOMA KINASE CHIMERIC ANTIGEN RECEPTORS AND METHODS OF USE

 #84
20230093678
2023-03-23

PEPTIDE IMMUNOGENS TARGETING PCSK9 AND FORMULATIONS THEREOF FOR PREVENTION AND TREATMENT OF PCSK9-MEDIATED DISORDERS

 #85
20230093483
2023-03-23

GLYCOTARGETING THERAPEUTICS

 #86
20230089465
2023-03-23

T CELL RECEPTORS RECOGNIZING MHC CLASS II-RESTRICTED MAGE-A3

 #87
20230088740
2023-03-23

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #88
20230087025
2023-03-23

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #89
20230077903
2023-03-16

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #90
20230065562
2023-03-02

DUAL CONTROLS FOR THERAPEUTIC CELL ACTIVATION OR ELIMINATION

 #91
20230053010
2023-02-16

Methods of Treating Glioblastoma

 #92
20230051404
2023-02-16

IMMUNOGENIC COMPOSITIONS COMPRISING NUCLEIC ACIDS FOR RAS PEPTIDES

 #93
20230042534
2023-02-09

SELF-ASSEMBLING SYNTHETIC PROTEINS

 #94
20230020626
2023-01-19

COMPOSITIONS AND METHODS FOR TREATING OBESITY AND HYPERPHAGIA

 #95
20230011870
2023-01-12

NANOVACCINE FOR HEART FAILURE

 #96
20220396556
2022-12-15

Lipid and Lipid Nanoparticle Formulation for Drug Delivery

 #97
20220380425
2022-12-01

ANGPTL3 BASED VACCINE FOR THE TREATMENT OF LIVER DISEASE

 #98
20220370578
2022-11-24

IMMUNOGENIC PEPTIDE FRAGMENTS OF METALLOPROTEASE ADAMTS-7 AND USES THEREOF IN ANTI-ATHEROSCLEROSIS AND RELATED DISEASES

 #99
20220356268
2022-11-10

Binding molecules for BCMA and CD3

 #100
20220331412
2022-10-20

ANTI-SIGLEC-8 ANTIBODIES AND METHODS OF USE THEREOF

 #101
20220323553
2022-10-13

Epigenomic editing and reactivation of targets for the treatment of Fragile X syndrome

 #102
20220313801
2022-10-06

BRACHYURY PROTEIN, NON-POXVIRUS NON-YEAST VECTORS ENCODING BRACHYURY PROTEIN, AND THEIR USE

 #103
20220305131
2022-09-29

MODIFIED VIRUS-LIKE PARTICLES OF CMV

 #104
20220288176
2022-09-15

CIRCULAR RNA MODIFICATION AND METHODS OF USE

 #105
20220267471
2022-08-25

Human Anti-SOD1 Antibodies

 #106
20220267374
2022-08-25

IMMUNITY INDUCER AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING AGING-RELATED DISEASES

 #107
20220265819
2022-08-25

TAU EPITOPE AND BINDING MOLECULES

 #108
20220259288
2022-08-18

HUMAN APOB100 EPITOPES, METHODS AND USES FOR MODULATING INFLAMMATORY RESPONSES, AND TREATING ADVERSE CARDIOVASCULAR EVENTS, DISEASE AND ATHEROSCLEROSIS

 #109
20220251666
2022-08-11

MUTANT CALRETICULIN FOR THE DIAGNOSIS OF MYELOID MALIGNANCIES

 #110
20220251243
2022-08-11

BINDING MOLECULES FOR BCMA AND CD3

 #111
20220218805
2022-07-14

CONFORMATION-SPECIFIC EPITOPES IN TAU, ANTIBODIES THERETO AND METHODS RELATED THEREOF

 #112
20220213168
2022-07-07

Peptides and combination of peptides for use in immunotherapy against various tumors

 #113
20220195013
2022-06-23

MULTI-EPITOPIC CONSTRUCT

 #114
20220193230
2022-06-23

COMPOSITIONS, COMPRISING IMPROVED IL-12 GENETIC CONSTRUCTS AND VACCINES, IMMUNOTHERAPEUTICS AND METHODS OF USING THE SAME

 #115
20220193087
2022-06-23

COMBINATION THERAPIES FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DISORDERS

 #116
20220177978
2022-06-09

METHODS OF PREDICTING AND PREVENTING CANCER IN PATIENTS HAVING PREMALIGNANT LESIONS

 #117
20220175977
2022-06-09

COMPOUNDS AND METHODS FOR THE DETECTION OF TRPV-6 CANCERS AND DRUG DELIVERY

 #118
20220168405
2022-06-02

TREATMENT OF PRURITUS IN HORSES

 #119
20220160848
2022-05-26

Immunogenic compositions comprising nucleic acids for RAS peptides

 #120
20220153798
2022-05-19

Recombinant proteins and their therapeutic uses

 #121
20220127377
2022-04-28

METHODS AND COMPOSITIONS FOR TREATING CANCER

 #122
20220118068
2022-04-21

Modulation of proprotein convertase subtilisin/kexin 9 expression (PCSK9) with HSP 27 and/or HSP25

 #123
20220106566
2022-04-07

Antigen-Presenting Neutrophil-Derived Dendritic Cells and Methods of Use Thereof

 #124
20220096614
2022-03-31

PEPTIDE-INDUCED NK CELL ACTIVATION

 #125
20220073596
2022-03-10

METHOD FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS

 #126
20220073582
2022-03-10

PEPTIDE IMMUNOGENS TARGETING CALCITONIN GENE-RELATED PEPTIDE (CGRP) AND FORMULATIONS THEREOF FOR PREVENTION AND TREATMENT OF MIGRAINE

 #127
20220064336
2022-03-03

Binding molecules for BCMA and CD3

 #128
20220064239
2022-03-03

Cathelicidin-expressing lactic acid bacteria

 #129
20220062394
2022-03-03

METHODS FOR IDENTIFYING NEOANTIGENS

 #130
20220056103
2022-02-24

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #131
20220041690
2022-02-10

Peptides and combination of peptides for use in immunotherapy against various tumors

 #132
20220041689
2022-02-10

Peptides and combination of peptides for use in immunotherapy against various tumors

 #133
20220040274
2022-02-10

METHOD FOR BLOCKING ANTIBODY ADMINISTRATION IN TRANSPLANTATION

 #134
20220033474
2022-02-03

STRUCTURE-SENSITIVE PEPTIDE ANTIGEN OF VON WILLEBRAND FACTOR

 #135
20220033469
2022-02-03

Peptides and combination of peptides for use in immunotherapy against various tumors

 #136
20220017598
2022-01-20

Peptides and combination of peptides for use in immunotherapy against various tumors

 #137
20220017595
2022-01-20

Peptides and combination of peptides for use in immunotherapy against various tumors

 #138
20220009995
2022-01-13

Peptides and combination of peptides for use in immunotherapy against various tumors

 #139
20220009985
2022-01-13

Methods and Compositions Relating to p62/SQSTM1 for the Treatment and Prevention of Inflammation-Associated Diseases

 #140
20220008534
2022-01-13

Combination Of Local And Systemic Immunomodulative Therapies For Enhanced Treatment of Cancer

 #141
20220002378
2022-01-06

Peptides and combination of peptides for use in immunotherapy against various tumors

 #142
20210403530
2021-12-30

Peptides and combination of peptides for use in immunotherapy against various tumors

 #143
20210401980
2021-12-30

Immunotherapy method comprising administering a combination of immune effector cells and non-target hematopoietic cells

 #144
20210401955
2021-12-30

CD4 T cells provide antibody access to immunoprivileged tissue

 #145
20210395338
2021-12-23

Peptides and combination of peptides for use in immunotherapy against various tumors

 #146
20210395337
2021-12-23

Peptides and combination of peptides for use in immunotherapy against various tumors

 #147
20210395336
2021-12-23

Peptides and combination of peptides for use in immunotherapy against various tumors

 #148
20210395335
2021-12-23

Peptides and combination of peptides for use in immunotherapy against various tumors

 #149
20210395334
2021-12-23

Peptides and combination of peptides for use in immunotherapy against various tumors

 #150
20210386843
2021-12-16

mRNA Vaccine

 #151
20210380664
2021-12-09

HCMV ENTRY INHIBITORS

 #152
20210369836
2021-12-02

SURFACE DISPLAY OF PROTEINS ON RECOMBINANT BACTERIA AND USES THEREOF

 #153
20210361766
2021-11-25

Vaccine compositions and methods of use

 #154
20210361736
2021-11-25

Vista antagonist and methods of use

 #155
20210353727
2021-11-18

IMMUNOMODULATORY THERAPY FOR TYPE 1 DIABETES MELLITUS AUTOIMMUNITY

 #156
20210346496
2021-11-11

CATIONIC LIPID VACCINE COMPOSITIONS AND METHODS OF USE

 #157
20210346476
2021-11-11

Modified FVIII Apitope Peptides

 #158
20210346475
2021-11-11

Immunization with polyvalent venom vaccines

 #159
20210338814
2021-11-04

COMBINATION OF IMMUNE EFFECTOR CELLS SPECIFIC FOR A TARGET ANTIGEN AND HEMATOPOIETIC CELLS THAT EXPRESS THE TARGET ANTIGEN IN AN ALTERED FORM

 #160
20210317165
2021-10-14

ZP3 FRAGMENTS IN IMMUNOTHERAPY OF OVARIAN CANCER

 #161
20210299236
2021-09-30

Methods and Compositions for Enhancing Vaccine Immune Responses

 #162
20210299235
2021-09-30

Methods of treating polycystic kidney disease

 #163
20210290921
2021-09-23

MICRODEVICES WITH COMPLEX GEOMETRIES

 #164
20210275649
2021-09-09

Compositions and methods for preventing tumors and cancer

 #165
20210253737
2021-08-19

METHODS AND COMPOSITIONS FOR TREATING DISEASE-RELATED CACHEXIA

 #166
20210253708
2021-08-19

VISTA Antagonist and Methods of Use

 #167
20210246164
2021-08-12

PEPTIDIC PROTEIN KINASE C INHIBITORS AND USES THEREOF

 #168
20210236608
2021-08-05

Compositions comprising a PCSK9 peptide conjugated to a qbeta carrier and methods of using the same

 #169
20210205425
2021-07-08

TREATMENT OF URTICARIA

 #170
20210188944
2021-06-24

Peptides and combination of peptides for use in immunotherapy against various tumors

 #171
20210188943
2021-06-24

Peptides and combination of peptides for use in immunotherapy against various tumors

 #172
20210187112
2021-06-24

Immunostimulatory compositions and methods of use thereof

 #173
20210179691
2021-06-17

Peptides and combination of peptides for use in immunotherapy against various tumors

 #174
20210170013
2021-06-10

Oil-based adjuvants

 #175
20210138048
2021-05-13

Peptide vaccines for hypercholesterolemia related diseases

 #176
20210128706
2021-05-06

VACCINE COMPOSITION

 #177
20210101965
2021-04-08

COMPLEMENT COMPONENT C5 ANTIBODIES

 #178
20210100898
2021-04-08

Methods of modulating immune responses with cationic lipid vaccine compositions

 #179
20210100897
2021-04-08

METHODS FOR THE STIMULATION OF DENDRITIC CELL (DC) PRECURSOR POPULATION "PRE-DC" AND THEIR USES THEREOF

 #180
20210095035
2021-04-01

Anti-galectin-1 (Gal1) monoclonal antibodies and fragments thereof for neutralizing Gal1

 #181
20210093700
2021-04-01

Anti-abeta therapeutic vaccines

 #182
20210087297
2021-03-25

Methods and compositions for treating pain associated with inflammation

 #183
20210085779
2021-03-25

PD1 AND PDL1 ANTIBODIES AND VACCINE COMBINATIONS AND USE OF SAME FOR IMMUNOTHERAPY

 #184
20210085766
2021-03-25

AMH-INH-GNIH tri-expression gene vaccine of improving fecundity of animals, preparation method and application

 #185
20210061894
2021-03-04

Immunological targeting of pathological tau proteins

 #186
20210046172
2021-02-18

BACTERIAL EXTRACELLULAR VESICLES HAVING REDUCED TOXICITY AND USE THEREOF

 #187
20210017230
2021-01-21

Compositions for expanding regulatory T cells (Treg), and treating autoimmune and inflammatory diseases and conditions

 #188
20210000837
2021-01-07

Heterocyclic compounds and uses thereof

 #189
20200407420
2020-12-31

HER-1, HER-3 AND IGF-1R COMPOSITIONS AND USES THEREOF

 #190
20200376116
2020-12-03

Method of inducing an immune response using an expression construct and GLA

 #191
20200368334
2020-11-26

Treatment of human immunodeficiency virus/acquired immunodeficiency syndrome

 #192
20200330570
2020-10-22

PEPTIDE AND METHOD FOR REDUCING THE PHOSPHATE REQUIREMENT AND EXCRETION FROM FARM ANIMALS

 #193
20200330569
2020-10-22

Peptide conjugated particles

 #194
20200325206
2020-10-15

Peptides and combination of peptides for use in immunotherapy against various tumors

 #195
20200316352
2020-10-08

Active agent delivery devices and methods of using the same

 #196
20200308250
2020-10-01

Peptides and combination of peptides for use in immunotherapy against various tumors

 #197
20200297827
2020-09-24

Self-assembling synthetic proteins

 #198
20200276228
2020-09-03

IMMUNE-MODIFYING NANOPARTICLES FOR THE TREATMENT OF INFLAMMATORY DISEASES

 #199
20200276227
2020-09-03

IMMUNE-MODIFYING NANOPARTICLES FOR THE TREATMENT OF INFLAMMATORY DISEASES

 #200
20200270331
2020-08-27

IMMUNOGENIC PEPTIDES AND THEIR USE IN TRANSPLANTATION

 #201
20200270329
2020-08-27

T CELL RECEPTORS RECOGNIZING MHC CLASS II-RESTRICTED MAGE-A3

 #202
20200268837
2020-08-27

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR MODULATING AUTOPHAGY

 #203
20200237884
2020-07-30

Cultured phagocyte supernatent compositions

 #204
20200230216
2020-07-23

Methods for inducing partial apoptosis using caspase polypeptides

 #205
20200179499
2020-06-11

STRATEGIES TO PREVENT AND/OR TREAT IMMUNE RESPONSES TO SOLUBLE ALLOFACTORS

 #206
20200171135
2020-06-04

CMV Vaccine and Method of Making and Using the Same

 #207
20200155699
2020-05-21

Modified virus-like particles of CMV

 #208
20200155649
2020-05-21

Compositions and methods for treating obesity and hyperphagia

 #209
20200148734
2020-05-14

Method for improving resistance to breakage and eggshell strength

 #210
20200138942
2020-05-07

Combination of local and systemic immunomodulative therapies for enhanced treatment of cancer

 #211
20200129629
2020-04-30

Glycotargeting therapeutics

 #212
20200129601
2020-04-30

Glycotargeting therapeutics

 #213
20200109172
2020-04-09

Compositions for expanding regulatory T cells (Treg) populations, and treating and ameliorating autoimmune diseases and conditions

 #214
20200093902
2020-03-26

Vista antagonist and methods of use

 #215
20200087378
2020-03-19

Relaxin1 derived peptides for use in immunotherapy

 #216
20200087352
2020-03-19

Assembly activating protein (AAP) and its use for the manufacture of parvovirus particles essentially consisting of VP3

 #217
20200085926
2020-03-19

Antigen fused with porcine Fc fragment and vaccine composition comprising the same

 #218
20200078366
2020-03-12

Combination therapies for the treatment of alzheimer's disease and related disorders

 #219
20200071401
2020-03-05

Multipartite signaling proteins and uses thereof

 #220
20200071399
2020-03-05

MULTIPARTITE SIGNALING PROTEINS AND USES THEREOF

 #221
20200061184
2020-02-27

Newcastle disease viruses and uses thereof

 #222
20200054723
2020-02-20

ANTI-SIGLEC-8 ANTIBODIES AND METHODS OF USE THEREOF

 #223
20200054678
2020-02-20

T CELL RECEPTORS DIRECTED AGAINST THE PREFERENTIALLY EXPRESSED ANTIGEN OF MELANOMA AND USES THEREOF

 #224
20200048342
2020-02-13

IMMUNOLOGICAL TREATMENT OF CEREBRAL AUTOSOMAL DOMINANT ARTERIOPATHY WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY

 #225
20200040399
2020-02-06

Mutant calreticulin for the diagnosis of myeloid malignancies

 #226
20200040060
2020-02-06

Peptides and combination of peptides for use in immunotherapy against various tumors

 #227
20200031905
2020-01-30

Human APOB100 epitopes, methods and uses for modulating inflammatory responses, and treating adverse cardiovascular events, disease and atherosclerosis

 #228
20200031899
2020-01-30

Peptides and combination of peptides for use in immunotherapy against various tumors

 #229
20200031898
2020-01-30

PEPTIDE MIMOTOPES OF CLAUDIN 18.2 AND USES THEREOF

 #230
20200024325
2020-01-23

Peptides and combination of peptides for use in immunotherapy against various tumors

 #231
20200023045
2020-01-23

Immunogenic composition targeting S100A9

 #232
20200016248
2020-01-16

Treatment of pruritus in horses

 #233
20200009219
2020-01-09

PHARMACEUTICAL CYCLOSPORIN COMPOSITIONS

 #234
20200009218
2020-01-09

ORAL PHARMACEUTICAL COMPOSITION

 #235
20190381155
2019-12-19

Combination of vaccination and inhibition of the PD-1 pathway

 #236
20190381154
2019-12-19

Beta-2 microglobulin-deficient cells

 #237
20190374635
2019-12-12

Method for reducing a myeloid derived suppressor cell population with cationic lipid vaccine compositions

 #238
20190374634
2019-12-12

Methods for improving immunological response in vaccinated animals

 #239
20190358318
2019-11-28

Vaccine compositions and methods of use

 #240
20190358308
2019-11-28

THROMBOXANE RECEPTOR-BASED VACCINE FOR MANAGING THROMBOGENESIS

 #241
20190337982
2019-11-07

PEPTIDIC PROTEIN KINASE C INHIBITORS AND USES THEREOF

 #242
20190315822
2019-10-17

Growth differentiation factor 15 (GDF-15) polypeptides

 #243
20190307867
2019-10-10

Anti-abeta therapeutic vaccines

 #244
20190300595
2019-10-03

Peptides and combination of peptides for use in immunotherapy against various tumors

 #245
20190298823
2019-10-03

P14.7 protein and uses thereof as vaccine adjuvant

 #246
20190290697
2019-09-26

IPSC-based vaccine as a prophylactic and therapeutic treatment for cancer

 #247
20190284302
2019-09-19

Human anti-SOD1 antibodies

 #248
20190275125
2019-09-12

ABETA VARIANTS, ASSAY, METHOD AND TREATMENT OF ALZHEIMER'S DISEASE

 #249
20190263933
2019-08-29

Activation of (Na+K)-atpase inhibits platelet aggregation and prevents thrombosis

 #250
20190262441
2019-08-29

Peptide conjugated particles for the treatment of inflammation

 #251
20190255160
2019-08-22

Vaccine composition

 #252
20190240301
2019-08-08

Vaccine composition

 #253
20190231858
2019-08-01

AUTOLOGOUS CELLS FOR IMMUNIZATION OF CHICKENS

 #254
20190216907
2019-07-18

COMPOSITIONS FOR AND METHODS OF TREATING AND PREVENTING CANCER TARGETING TUMOR ASSOCIATED CARBOHYDRATE ANTIGENS

 #255
20190216906
2019-07-18

POLYVALENT VENOM VACCINES, METHODS OF USE AND MAKING

 #256
20190209717
2019-07-11

Compounds and methods for the detection of TRPV-6 cancers and drug delivery

 #257
20190201540
2019-07-04

IMMUNOGENS, COMPOSITIONS, AND METHODS FOR TREATING DYSLIPIDEMIA

 #258
20190201510
2019-07-04

PASSIVE VACCINE FOR ELIMINATION OF SENESCENT CELLS

 #259
20190194280
2019-06-27

PEPTIDE VACCINE FOR PREVENTION AND IMMUNOTHERAPY OF DEMENTIA OF THE ALZHEIMER'S TYPE

 #260
20190185542
2019-06-20

HER-1, HER-3 and IGF-1R compositions and uses thereof

 #261
20190185540
2019-06-20

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #262
20190169287
2019-06-06

TREATMENT OF CANCER WITH ANTI-IL-1 ALPHA ANTIBODIES

 #263
20190161532
2019-05-30

HCMV entry inhibitors

 #264
20190160161
2019-05-30

Multivalent biologic constructs for inducing a therapeutic modulation of cellular response and uses thereof

 #265
20190153117
2019-05-23

EPITOPES OF EPIDERMAL GROWTH FACTOR RECEPTOR SURFACE ANTIGEN AND USE THEREOF

 #266
20190153056
2019-05-23

Methods and compositions relating to p62/SQSTM1 for the treatment and prevention of inflammation-associated diseases

 #267
20190142936
2019-05-16

Dry solid aluminum adjuvant-containing vaccines and related methods thereof

 #268
20190134170
2019-05-09

Composition comprising PCSK9 peptide conjugated to a Qbeta carrier and methods of using the same

 #269
20190127473
2019-05-02

Anti-galectin-1 (GAL1) monoclonal antibodies and fragments thereof for neutralizing GAL1

 #270
20190125847
2019-05-02

Methods, antibodies, and vaccines utilizing epitopes of alpha synuclein for treatment of Parkinson's disease

 #271
20190119352
2019-04-25

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

 #272
20190119351
2019-04-25

Peptides and combination of peptides for use in immunotherapy against various tumors

 #273
20190117793
2019-04-25

MODULAR NANODEVICES FOR SMART ADAPTABLE VACCINES

 #274
20190117748
2019-04-25

Glycosylated oligonucleotides that mimic the HIV-1 epitope of neutralizing monoclonal antibody 2G12

 #275
20190117561
2019-04-25

SELF-ASSEMBLED NANOPARTICLE RELEASING SOLUBLE MICRONEEDLE STRUCTURE AND PREPARATION METHOD THEREFOR

 #276
20190112372
2019-04-18

Multipartite signaling proteins and uses thereof

 #277
20190092857
2019-03-28

Method of modulating the adrenomedullin (ADM) activity of a patient by administering to the patient an anti-ADM antibody or fragment thereof that specifically binds to mature human ADM

 #278
20190091306
2019-03-28

Method for vaccination against a self-antigen in a human patient

 #279
20190083408
2019-03-21

Controlled-release peptide compositions and uses thereof

 #280
20190076631
2019-03-14

MICRODEVICES WITH COMPLEX GEOMETRIES

 #281
20190060354
2019-02-28

Immune-modifying nanoparticles for the treatment of inflammatory diseases

 #282
20190055294
2019-02-21

Compositions Comprising Hypoxia Inducible Factor-1 Alpha and Methods of Using the Same

 #283
20190046619
2019-02-14

Brachyury protein, non-poxvirus non-yeast vectors encoding Brachyury protein, and their use

 #284
20190046618
2019-02-14

METHODS OF INHIBITING GONAD MATURATION

 #285
20190038737
2019-02-07

Oil-based adjuvants

 #286
20190030142
2019-01-31

Polyvalent venom vaccines

 #287
20190023762
2019-01-24

Peptides and combination of peptides for use in immunotherapy against various tumors

 #288
20190022206
2019-01-24

Virus like particle with efficient epitope display

 #289
20190022197
2019-01-24

MODULATION OF YEAST-BASED IMMUNOTHERAPY PRODUCTS AND RESPONSES

 #290
20190015522
2019-01-17

Immunostimulatory compositions and methods of use thereof

 #291
20190010226
2019-01-10

Anti-adrenomedullin (ADM) monoclonal antibodies and anti-ADM monoclonal antibody fragments that bind to adrenomedullin

 #292
20190010211
2019-01-10

Fusion proteins comprising partial tetraspanin sequences and a system thereof for presenting peptides on the cell surface

 #293
20190002524
2019-01-03

Peptides and combination of peptides for use in immunotherapy against various tumors

 #294
20180362586
2018-12-20

Compositions for expanding regulatory T cells (Treg), and treating autoimmune and inflammatory diseases and conditions

 #295
20180360956
2018-12-20

Method of reducing reactogenicity induced by administration of vaccine or immunogenic composition

 #296
20180360933
2018-12-20

Inotropic antibodies and therapeutic uses thereof

 #297
20180346548
2018-12-06

Peptides and combination of peptides for use in immunotherapy against various tumors

 #298
20180340019
2018-11-29

Peptides and combination of peptides for use in immunotherapy against various tumors

 #299
20180333485
2018-11-22

Compositions, comprising improved IL-12 genetic constructs and vaccines, immunotherapeutics and methods of using the same

 #300
20180327475
2018-11-15

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS